Cheyne Capital Management (UK)’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-25,000
| Closed | -$651K | – | 115 |
|
2021
Q2 | $651K | Buy |
+25,000
| New | +$651K | 0.3% | 59 |
|
2020
Q4 | – | Sell |
-17,250
| Closed | -$568K | – | 95 |
|
2020
Q3 | $568K | Buy |
+17,250
| New | +$568K | 0.28% | 51 |
|
2020
Q1 | – | Sell |
-80,000
| Closed | -$2.21M | – | 46 |
|
2019
Q4 | $2.21M | Sell |
80,000
-71,500
| -47% | -$1.98M | 1.34% | 32 |
|
2019
Q3 | $2.76M | Sell |
151,500
-35,000
| -19% | -$637K | 1.74% | 27 |
|
2019
Q2 | $4.57M | Hold |
186,500
| – | – | 3.32% | 11 |
|
2019
Q1 | $1.77M | Hold |
186,500
| – | – | 1.66% | 26 |
|
2018
Q4 | $1.65M | Sell |
186,500
-13,500
| -7% | -$120K | 1.56% | 24 |
|
2018
Q3 | $2.25M | Buy |
+200,000
| New | +$2.25M | 1.34% | 31 |
|